We did not find any strong evidence of an impact of previously published type 2 diabetes genetic variants on glucagon levels during OGTT, except for EYA2. Neither did we find a large number of novel genetic variants affecting glucagon levels during OGTT in the GWAS performed here. Here, GCG is linked to type 2 diabetes mellitus.